» Articles » PMID: 26833155

Amino Acid Substitutions Account for Most MexS Alterations in Clinical NfxC Mutants of Pseudomonas Aeruginosa

Overview
Specialty Pharmacology
Date 2016 Feb 3
PMID 26833155
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Multidrug-resistant mutants ofPseudomonas aeruginosathat overproduce the active efflux system MexEF-OprN (callednfxCmutants) have rarely been characterized in the hospital setting. Screening of 221 clinical strains exhibiting a reduced susceptibility to ciprofloxacin (a substrate of MexEF-OprN) and imipenem (a substrate of the negatively coregulated porin OprD) led to the identification of 43 (19.5%)nfxCmutants. Subsequent analysis of 22 nonredundant mutants showed that, in contrast to theirin vitro-selected counterparts, only 3 of them (13.6%) harbored a disruptedmexSgene, which codes for the oxidoreductase MexS, whose inactivation is known to activate themexEF-oprNoperon through a LysR-type regulator, MexT. Nine (40.9%) of the clinicalnfxCmutants contained single amino acid mutations in MexS, and these were associated with moderate effects on resistance and virulence factor production in 8/9 strains. Finally, the remaining 10 (45.5%)nfxCmutants did not display mutations in any of the regulators known to controlmexEF-oprNexpression (themexS,mexT,mvaT, andampRgenes), confirming that other loci are responsible for pump upregulation in patients. Collectively, these data demonstrate thatnfxCmutants are probably more frequent in the hospital than previously thought and have genetic and phenotypic features somewhat different from those ofin vitro-selected mutants.

Citing Articles

Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae.

Mammeri H, Sereme Y, Toumi E, Faury H, Skurnik D PLoS Pathog. 2025; 21(2):e1012902.

PMID: 39919103 PMC: 11805372. DOI: 10.1371/journal.ppat.1012902.


Evolutionary loss of an antibiotic efflux pump increases quorum sensing mediated virulence .

Fernandes S, Ortega H, Vaillancourt M, Galdino A, Stotland A, Mun K Res Sq. 2024; .

PMID: 39606469 PMC: 11601840. DOI: 10.21203/rs.3.rs-5391023/v1.


Regulation of Safracin Biosynthesis and Transport in PMA22.

Hernandez Delgado J, Acedos M, de la Calle F, Rodriguez P, Garcia J, Galan B Mar Drugs. 2024; 22(9).

PMID: 39330299 PMC: 11432991. DOI: 10.3390/md22090418.


Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.

Karlowsky J, Wise M, Hackel M, Six D, Uehara T, Daigle D J Antimicrob Chemother. 2024; 79(12):3116-3131.

PMID: 39287999 PMC: 11638001. DOI: 10.1093/jac/dkae329.


Molecular characterization of clinically isolated with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021.

Li H, Oliver A, Shields R, Kamat S, Stone G, Estabrook M Antimicrob Agents Chemother. 2024; 68(10):e0067024.

PMID: 39254297 PMC: 11459925. DOI: 10.1128/aac.00670-24.


References
1.
Lamarche M, Deziel E . MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS One. 2011; 6(9):e24310. PMC: 3177830. DOI: 10.1371/journal.pone.0024310. View

2.
Jin Y, Yang H, Qiao M, Jin S . MexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosa. J Bacteriol. 2010; 193(2):399-410. PMC: 3019812. DOI: 10.1128/JB.01079-10. View

3.
Gellatly S, Hancock R . Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis. 2013; 67(3):159-73. DOI: 10.1111/2049-632X.12033. View

4.
Linares J, Lopez J, Camafeita E, Albar J, Rojo F, Martinez J . Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa. J Bacteriol. 2005; 187(4):1384-91. PMC: 545608. DOI: 10.1128/JB.187.4.1384-1391.2005. View

5.
Ohman D, Cryz S, Iglewski B . Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol. 1980; 142(3):836-42. PMC: 294108. DOI: 10.1128/jb.142.3.836-842.1980. View